PubMed

Dual mechanism for the impairment of IL-7 responses in HIV infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.

Juffroy O, Bugault F, Lambotte O, Landires I, Viard JP, Niel L, Fontanet A, Delfraissy JF, Thèze J, Chakrabarti LA.

J Virol. 2009 Oct 28. [Epub ahead of print]PMID: 19864382 [PubMed - as supplied by publisher]Related articles

Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03).

Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L, Delaneau O, Labib T, Sladek R; ANRS Genomic Group, Deveau C, Guillemain H, Ratsimandresy R, Montes M, Spadoni JL, Therwath A, Schächter F, Matsuda F, Gut I, Lelièvre JD, Lévy Y, Froguel P, Delfraissy JF, Hercberg S, Zagury JF.

J Infect Dis. 2009 Oct 15;200(8):1194-201.PMID: 19754311 [PubMed - indexed for MEDLINE]Related articles

Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established?

Goujard C, Chaix ML, Lambotte O, Deveau C, Sinet M, Guergnon J, Courgnaud V, Rouzioux C, Delfraissy JF, Venet A, Meyer L; Agence Nationale de Recherche sur le Sida PRIMO Study Group.

Clin Infect Dis. 2009 Sep 15;49(6):982-6.PMID: 19681706 [PubMed - indexed for MEDLINE]Related articles

Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.

Sáez-Cirión A, Sinet M, Shin SY, Urrutia A, Versmisse P, Lacabaratz C, Boufassa F, Avettand-Fènoël V, Rouzioux C, Delfraissy JF, Barré-Sinoussi F, Lambotte O, Venet A, Pancino G; ANRS EP36 HIV Controllers Study Group.

J Immunol. 2009 Jun 15;182(12):7828-37.PMID: 19494307 [PubMed - indexed for MEDLINE]Related articles

Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients.

Rose T, Lambotte O, Pallier C, Delfraissy JF, Colle JH.

J Immunol. 2009 Jun 15;182(12):7389-97.PMID: 19494261 [PubMed - indexed for MEDLINE]Related articles

Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen.

Ghosn J, Mazet AA, Avettand-Fenoel V, Peytavin G, Wirden M, Delfraissy JF, Chaix ML.

J Antimicrob Chemother. 2009 Aug;64(2):433-4. Epub 2009 May 20. No abstract available. PMID: 19457931 [PubMed - indexed for MEDLINE]Related articles

HIV infection impairs CCR7-dependent T-cell chemotaxis independent of CCR7 expression.

Perez-Patrigeon S, Vingert B, Lambotte O, Viard JP, Delfraissy JF, Thèze J, Chakrabarti LA.

AIDS. 2009 Jun 19;23(10):1197-207.PMID: 19455014 [PubMed - in process]Related articles

Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.

Delaugerre C, Flandre P, Chaix ML, Ghosn J, Raffi F, Dellamonica P, Jaeger H, Shürmann D, Cohen-Codar I, Van PN, Norton M, Taburet AM, Delfraissy JF, Rouzioux C; MONARK Study Group.

Antimicrob Agents Chemother. 2009 Jul;53(7):2934-9. Epub 2009 May 18.PMID: 19451297 [PubMed - indexed for MEDLINE]Related articles

No evidence of a change in HIV-1 virulence since 1996 in France.

Troude P, Chaix ML, Tran L, Deveau C, Seng R, Delfraissy JF, Rouzioux C, Goujard C, Meyer L; ANRS Primo cohort.

AIDS. 2009 Jun 19;23(10):1261-7.PMID: 19424055 [PubMed - in process]Related articles

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers.

Lambotte O, Ferrari G, Moog C, Yates NL, Liao HX, Parks RJ, Hicks CB, Owzar K, Tomaras GD, Montefiori DC, Haynes BF, Delfraissy JF.

AIDS. 2009 May 15;23(8):897-906.PMID: 19414990 [PubMed - in process]Related articles

Soluble IL-7Ralpha (sCD127) and measurement of IL-7 in the plasma of HIV patients.

Blom-Potar MC, Bugault F, Lambotte O, Delfraissy JF, Thèze J.

J Acquir Immune Defic Syndr. 2009 May 1;51(1):104-5. No abstract available. PMID: 19390329 [PubMed - indexed for MEDLINE]Related articles

Prognostic factors for virological response in antiretroviral therapy-naive patients in the MONARK Trial randomized to ritonavir-boosted lopinavir alone.

Flandre P, Delaugerre C, Ghosn J, Chaix ML, Horban A, Girard PM, Gladysz A, Cohen-Codar I, Van PN, Taburet AM, Rouzioux C, Delfraissy JF; MONARK Study Group.

Antivir Ther. 2009;14(1):93-7.PMID: 19320241 [PubMed - indexed for MEDLINE]Related articles

Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Levy Y, Lacabaratz C, Weiss L, Viard JP, Goujard C, Lelièvre JD, Boué F, Molina JM, Rouzioux C, Avettand-Fénoêl V, Croughs T, Beq S, Thiébaut R, Chêne G, Morre M, Delfraissy JF.

J Clin Invest. 2009 Apr;119(4):997-1007. doi: 10.1172/JCI38052. Epub 2009 Mar 16.PMID: 19287090 [PubMed - indexed for MEDLINE]Related articlesFree article

Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02).

Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R, Deveau C, Ratsimandresy R, Montes M, Spadoni JL, Lelièvre JD, Lévy Y, Therwath A, Schächter F, Matsuda F, Gut I, Froguel P, Delfraissy JF, Hercberg S, Zagury JF; ANRS Genomic Group.

J Infect Dis. 2009 Feb 1;199(3):419-26.PMID: 19115949 [PubMed - indexed for MEDLINE]Related articles

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study.

Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, Chaix ML, Lambotte O, Avettand-Fenoel V, Le Clerc S, de Senneville LD, Deveau C, Boufassa F, Debré P, Delfraissy JF, Broet P, Theodorou I; ANRS Genome Wide Association 01.

PLoS One. 2008;3(12):e3907. Epub 2008 Dec 24.PMID: 19107206 [PubMed - indexed for MEDLINE]Related articlesFree article

Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection.

De Lavaissière M, Manceron V, Bourée P, Garçon L, Bisaro F, Delfraissy JF, Lambotte O, Goujard C.

J Infect. 2009 Mar;58(3):245-7. Epub 2008 Dec 17.PMID: 19095307 [PubMed - indexed for MEDLINE]Related articles

Switching to darunavir/ritonavir achieves viral suppression in patients with persistent low replication on first-line lopinavir/ritonavir.

Chaix ML, Sahali S, Pallier C, Barrail-Tran A, Delfraissy JF, Ghosn J.

AIDS. 2008 Nov 12;22(17):2405-7. No abstract available. PMID: 18981786 [PubMed - indexed for MEDLINE]Related articles

Rapid CD4+ Cell Decrease After Transient cART Initiated During Primary HIV Infection (ANRS PRIMO and SEROCO Cohorts).

Seng R, Goujard C, Desquilbet L, Sinet M, Rouzioux C, Deveau C, Boufassa F, Delfraissy JF, Meyer L, Venet A; and the ANRS PRIMO and SEROCO Study Groups.

J Acquir Immune Defic Syndr. 2008 Oct 3. [Epub ahead of print]PMID: 18845952 [PubMed - as supplied by publisher]Related articles

Rapid CD4+ cell decrease after transient cART initiated during primary HIV infection (ANRS PRIMO and SEROCO cohorts).

Seng R, Goujard C, Desquilbet L, Sinet M, Rouzioux C, Deveau C, Boufassa F, Delfraissy JF, Meyer L, Venet A; and the ANRS PRIMO and SEROCO Study Groups.

J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):251-8.PMID: 18845951 [PubMed - indexed for MEDLINE]Related articles

Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy.

Tran TA, de Goër de Herve MG, Hendel-Chavez H, Dembele B, Le Névot E, Abbed K, Pallier C, Goujard C, Gasnault J, Delfraissy JF, Balazuc AM, Taoufik Y.

PLoS One. 2008 Oct 1;3(10):e3305.PMID: 18827929 [PubMed - indexed for MEDLINE]Related articlesFree article